New insights into the treatment of acute otitis media.
Document Type
Article
Publication Date
5-2023
Identifier
DOI: 10.1080/14787210.2023.2206565
Abstract
INTRODUCTION: Acute otitis media (AOM) affects most (80%) children by 5 years of age and is the most common reason children are prescribed antibiotics. The epidemiology of AOM has changed considerably since the widespread use of pneumococcal conjugate vaccines, which has broad-reaching implications for management.
AREAS COVERED: In this narrative review, we cover the epidemiology of AOM, best practices for diagnosis and management, new diagnostic technology, effective stewardship interventions, and future directions of the field. Literature review was performed using PubMed and ClinicalTrials.gov.
EXPERT OPINION: Inaccurate diagnoses, unnecessary antibiotic use, and increasing antimicrobial resistance remain major challenges in AOM management. Fortunately, effective tools and interventions to improve diagnostic accuracy, de-implement unnecessary antibiotic use, and individualize care are on the horizon. Successful scaling of these tools and interventions will be critical to improving overall care for children.
Journal Title
Expert review of anti-infective therapy
Volume
21
Issue
5
First Page
523
Last Page
534
MeSH Keywords
Child; Humans; Infant; Acute Disease; Otitis Media; Anti-Bacterial Agents; Pneumococcal Vaccines
Keywords
Acute otitis media; amoxicillin; antibiotic stewardship; pneumococcal vaccines; treatment
Recommended Citation
El Feghaly RE, Nedved A, Katz SE, Frost HM. New insights into the treatment of acute otitis media. Expert Rev Anti Infect Ther. 2023;21(5):523-534. doi:10.1080/14787210.2023.2206565
Comments
Grant support